Part, Chapter, Paragraph
1 II, 5. 1. 1| establish preventive policies. Screening and case identification
2 II, 5. 1. 1| and once detected early by screening via PAP-smear test, these
3 II, 5. 2. 5| population-based registers and screening programmes. These approaches
4 II, 5. 3. 1| for their implication in screening activity; prostate and stomach
5 II, 5. 3. 2| hospices, private hospitals, screening registries, other CRs, primary
6 II, 5. 3. 2| Contributing to the evaluation of screening programmes: a number of
7 II, 5. 3. 2| efficient evaluation of screening programmes. Others could
8 II, 5. 3. 2| or lapsed attendance to screening programmes;~- impact indicators:
9 II, 5. 3. 2| prevalent wave of cases after screening introduction; trends in
10 II, 5. 3. 2| impact evaluation of cancer screening and cancer treatment programmes:~·
11 II, 5. 3. 2| control, including incidence, screening and survival;~· EU-wide
12 II, 5. 3. 4| and once detected early by screening via PAP-smear test, these
13 II, 5. 3. 5| different introduction of screening programs in various countries
14 II, 5. 3. 5| Parkin et al, 2005). The screening effect on the incidence
15 II, 5. 3. 5| the years following full screening implementation.~Figure 5.
16 II, 5. 3. 5| rates can be influenced by screening programmes. In this case,
17 II, 5. 3. 5| programmes. In this case, screening detects cervical lesions
18 II, 5. 3. 5| exposure and the organised screening is implemented in the second,
19 II, 5. 3. 5| different introduction of screening programmes in various countries.
20 II, 5. 3. 5| difficulties to implement cervical screening programs. There have been
21 II, 5. 3. 5| there are well-developed screening programs.~ ~Figure 5.3.21.
22 II, 5. 3. 6| with effective cervical screening programmes tends to reflect
23 II, 5. 3. 6| aggressive cancers for which screening has failed, survival in
24 II, 5. 3. 6| are no organised cervical screening programmes. This suggests
25 II, 5. 3. 6| infrastructure, prevention and screening programmes, access to diagnostic
26 II, 5. 3. 7| over-exposure to sunlight, and screening for cancer are all recommended
27 II, 5. 3. 7| secondary prevention or screening)~ ~An organised (or mass)
28 II, 5. 3. 7| An organised (or mass) screening programme must be seen as
29 II, 5. 3. 7| at an earlier stage via screening test. The overall effectiveness
30 II, 5. 3. 7| overall effectiveness of a screening programme is determined
31 II, 5. 3. 7| population level. Organised screening programmes are likely to
32 II, 5. 3. 7| spontaneous (opportunistic) screening. Opportunistic screening
33 II, 5. 3. 7| screening. Opportunistic screening should be discouraged. Mass
34 II, 5. 3. 7| should be discouraged. Mass screening programmes can be more thoroughly
35 II, 5. 3. 7| easily. For instance, mass screening for neuroblastoma in Japan
36 II, 5. 3. 7| Ideally, an organised screening programme should be prepared
37 II, 5. 3. 7| eligible persons invited for screening about both the favourable
38 II, 5. 3. 7| effects anticipated from screening, so that their choice can
39 II, 5. 3. 7| public health effects of a screening programme, and its costs,
40 II, 5. 3. 7| carefully predicted before screening is implemented, and the
41 II, 5. 3. 7| ultimate purpose of cancer screening is to reduce cancer mortality,
42 II, 5. 3. 7| Hakama and De Konig, 2007).~ ~Screening has been shown to reduce
43 II, 5. 3. 7| The situation of cervical screening in Eastern Europe is one
44 II, 5. 3. 7| that effective organised screening programmes could drastically
45 II, 5. 3. 7| organised population-based screening should be promoted for the
46 II, 5. 3. 7| implementation of organised screening programmes (European Council,
47 II, 5. 3. 7| women aged 25 to 64 for the screening of cervical pre-cancer lesions (
48 II, 5. 3. 7| to 69 for breast cancer screening (with 2 or 3 years of interval)
49 II, 5. 3. 7| women aged 50 to 74 for the screening of colorectal cancer (with
50 II, 5. 3. 7| evidence of the efficacy of screening is often misleading, due
51 II, 5. 3. 7| Europe to establish whether screening for prostate cancer or lung
52 II, 5. 3. 7| lung or prostate cancer screening.~ ~
53 II, 5. 3. 7| for primary prevention, screening, early diagnosis and treatment,
54 II, 5. 3. 8| implementing organized cancer screening programmes and investing
55 II, 5. 3. 9| December 2003 on cancer screening. htt f (document online,
56 II, 5. 3. 9| A halt to neuroblastoma screening in Japan. N Engl J Med 350:
57 II, 5. 4. 2| diffusion of opportunistic screening among high risk individuals
58 II, 5. 4. 2| cholesterol testing~Annual screening for nephropathy~Annual eye
59 II, 5. 4. 6| al (2007), the scope for screening undiagnosed diabetes has
60 II, 5. 4. 6| 3. Secondary prevention~Screening may be an important weapon
61 II, 5. 4. 6| WHO 2003 report defines screening as the process used for
62 II, 5. 4. 6| This is one case in which screening on an annual basis should
63 II, 5. 4. 6| considering population-based screening, the screening of hyperglycaemia,
64 II, 5. 4. 6| population-based screening, the screening of hyperglycaemia, alone
65 II, 5. 4. 6| evidence-based disease prevention, screening~· and management founded
66 II, 5. 4. 7| health promotion and prevention to screening, diagnosis, treatment and
67 II, 5. 4. 8| 1995) A computerized health screening and follow-up system in
68 II, 5. 4. 8| 3):117-37~Waug A (2007): Screening for type 2 diabetes: literature
69 II, 5. 5. 3| al, 1998); moreover, also screening procedures and validations
70 II, 5. 5. 3| identified studies. Furthermore, screening personnel had different
71 II, 5. 5. 3| consequence of false-negative screening results, prevalence may
72 II, 5. 6. 6| effect of risk factors on screening strategies. Bone 30:251-
73 II, 5. 6. 6| risk and its application to screening for postmenopausal osteoporosis:
74 II, 5. 7. 1| 2005) may be useful for the screening of CKD; indeed, studies
75 II, 5. 7. 5| still uncertain whether screening the general population for
76 II, 5. 7. 5| Foundation, 2002 79 /id}. Mass screening through the measurement
77 II, 5. 7. 5| treatment of neoplasia, screening for CKD appears advisable.
78 II, 5. 7. 5| with chronic infections, screening for CKD could be implemented
79 II, 5. 7. 6| development of meaningful screening strategies and prevention
80 II, 5. 7. 7| Cost-effectiveness of screening for albuminuria and subsequent
81 II, 5. 7. 7| Brancati FL, Powe NR (2003): Screening for proteinuria in US adults:
82 II, 5. 7. 7| 2005): The validity of screening based on spot morning urine
83 II, 5. 7. 7| Holmen J, et al (2006b): Screening strategies for chronic kidney
84 II, 5. 8. 3| Authors affirmed that a screening of patients with COPD would
85 II, 5. 8. 5| studies have focused on the screening of the population at risk,
86 II, 5. 8. 5| by means of spirometric screening (Gorecka et al, 2003). The
87 II, 5. 8. 5| large-scale voluntary spirometry screening of the population at high
88 II, 5. 8. 7| of COPD in primary care: screening by invitation of smokers
89 II, 5. 9. 2| subjects were given the ECRHS screening questionnaire dealing with
90 II, 5. 9. 2| subjects who had completed the screening questionnaire, skin prick
91 II, 5. 9. 4| Phadiatop as an in-vitro screening test for atopy) was 32.3%,
92 II, 5. 9. 4| quantitative assay for the screening of allergy adjuvant activity
93 II, 5. 9. 4| gasoline engine PM. They are screening the samples for bioactivity
94 II, 5. 11. 5| participate by holding a screening day.~All of the participating
95 II, 5. 12. 5| and no diagnostic test or screening program which can be recommended
96 II, 6. 3. 1| investigation, or as part of a screening programme. For many of the
97 II, 6. 3. 3| collection for STI, e.g. through screening programmes where cost-effective,
98 II, 6. 3. 3| preventive campaigns and screening programmes could be exchanged
99 II, 6. 3. 3| differences in data collection. Screening studies in Europe have shown
100 II, 8. 2. 1| and preventative health screening have been identified among
101 II, 8. 2. 1| 2006) note, regular health screening can detect unmet health
102 II, 8. 2. 1| following a clinical health screening intervention for participants
103 II, 8. 2. 1| suggest that implementing such screening would reduce health inequalities.~
104 II, 8. 2. 1| termination of pregnancy. Screening programmes may also prevent
105 II, 8. 2. 1| disabilities: outcomes of a health screening programme after 1 year.
106 II, 8. 2. 2| provision. It is important that screening of children for refractive
107 II, 9. 1. 1| at high risk~ F: Neonatal screening policies~Maternal health~
108 II, 9. 1. 2| financial cost of prenatal screening in the population and its
109 II, 9. 1. 2| diagnosed through neonatal screening may be included in congenital
110 II, 9. 1. 2| births. Differing prenatal screening policies and practices,
111 II, 9. 1. 2| differences in uptake of screening and diagnosis due to cultural
112 II, 9. 1. 2| Syndrome, 1992-2004~ ~Prenatal screening for Down Syndrome has resulted
113 II, 9. 1. 2| practice regarding prenatal screening and TOPFA, as well as maternal
114 II, 9. 1. 2| developments.~ ~Prenatal screening and diagnosis~ ~The two
115 II, 9. 1. 2| two main types of prenatal screening are biochemical screening
116 II, 9. 1. 2| screening are biochemical screening and ultrasound scanning
117 II, 9. 1. 2| is increasingly used, but screening developments are unevenly
118 II, 9. 1. 2| Europe (EUROCAT, 2005). Screening policies vary between European
119 II, 9. 1. 2| design and implementation of screening, or from differences in
120 II, 9. 1. 2| effect.~ ~However, prenatal screening also presents to the healthcare
121 II, 9. 1. 2| rare anomalies. Inevitably, screening involves both false positives
122 II, 9. 1. 2| this situation.~ ~Prenatal screening and diagnosis have seen
123 II, 9. 1. 2| Variation in the quality of screening services within Europe requires
124 II, 9. 1. 2| Special Report: Prenatal Screening Policies in Europe". EUROCAT
125 II, 9. 1. 2| Psychosocial aspects of genetic screening of pregnant women and newborns:
126 II, 9. 3. 1| England have announced that a screening programme for men aged 65
127 II, 9. 3. 1| 2007): Prostate Cancer Screening Decreases the Absolute Risk
128 II, 9. 3. 1| Forciea, MA Owens, DK (2008). "Screening for Osteoporosis in Men:
129 II, 9. 3. 2| 2004). Improved antenatal screening techniques bring up the
130 II, 9. 4. 3| differences in access to screening (Qinn et al, 2001).~ ~Communicable
131 II, 9. 5. 3| lifestyle choices and access to screening and treatment, may adversely
132 II, 9. 5. 4| Lisbon Nov 2007), National Screening England Chlamydia (2007)
133 II, 9. 5. 4| prostate cancer and colorectal screening guidelines (COM (2003) 0230,
134 II, 9. 5. 4| Recommendation on cancer screening).~ ~Steps to improve men’
135 III, 10. 2. 1| cost-effectiveness of opportunistic screening and brief interventions
136 III, 10. 2. 1| is intended for use as a screening tool for preliminary exposure
137 III, 10. 2. 4| the shift from carrier screening to a screening based on
138 III, 10. 2. 4| from carrier screening to a screening based on individual genomic
139 III, 10. 2. 4| population (e.g. newborn screening, breast cancer screening,
140 III, 10. 2. 4| screening, breast cancer screening, HIV screening, specific
141 III, 10. 2. 4| breast cancer screening, HIV screening, specific screening options
142 III, 10. 2. 4| HIV screening, specific screening options for migrants, carrier
143 III, 10. 2. 4| options for migrants, carrier screening). At present we already
144 III, 10. 4. 2| enable the collection of all screening data from a sample, with
145 IV, 11. 1. 5| mammography and cervical cancer screening, waiting time for femur
146 IV, 11. 1. 5| cancer and cervical cancer screening, data are so far available
147 IV, 11. 1. 5| less). For cervical cancer screening, rates are lower than for
148 IV, 11. 1. 5| to increase the rate of screening among the target populations (
149 IV, 11. 2. 2| the above limitations is screening. In terms of mental health,
150 IV, 11. 4 | stroke~· Population based screening programmes to reduce the
151 IV, 11. 6. 5| Holland WW, Stewart S (2005): Screening in disease prevention: what
152 IV, 11. 6. 5| Stewart S et al. (2006): Screening in Europe: A policy brief.
153 IV, 12. 1 | detection and systematic screening, quality of care, and research.~
154 IV, 12. 2 | population-based registers and screening programmes. These approaches
155 IV, 12. 2 | for improved prevention, screening and treatment of the disease
156 IV, 12. 2 | organised population-based screening should be promoted for the
157 IV, 12. 2 | implementation of organised screening programmes (European Council,
158 IV, 12. 2 | women between 20-30 for the screening of cervical pre-cancer lesions (
159 IV, 12. 2 | to 69 for breast cancer screening (with 2 or 3 years of interval)
160 IV, 12. 2 | women aged 50 to 74 for the screening of colorectal cancer (with
161 IV, 12. 2 | ultimate purpose of cancer screening is to reduce cancer mortality,
162 IV, 12. 2 | present.~ ~The case for screening for undiagnosed diabetes
163 IV, 12. 2 | over-emphasised. The rationale of screening is to detect a disease or
164 IV, 12. 2 | WHO 2003 report defines screening as the process of identifying
165 IV, 12. 2 | cost-effectiveness of opportunistic screening and brief interventions
166 IV, 12. 10 | Environment Act (Adjustment of screening visits, consultancy services
167 IV, 12. 10 | for individuals; health screening is free of charge, regularly,
168 IV, 12. 10 | of the population through screening, treatment and rehabilitation
169 IV, 12. 10 | food/water/air safety, screening and emergency planning.~ ~
170 IV, 12. 10 | care from prevention and screening through to treatment services,
171 IV, 12. 10 | cardiovascular diseases, screening for risk factors, including
172 IV, 12. 10 | possibilities for all to smoke.~Screening programmes~As part of the
173 IV, 12. 10 | issued on 21 December 2006 a Screening Decree (1339/2006) which
174 IV, 12. 10 | effectiveness of the various screening methodologies and of screening
175 IV, 12. 10 | screening methodologies and of screening programmes based on them.
176 IV, 12. 10 | issues equal criteria for all screening programmes issued as part
177 IV, 12. 10 | work in Finland.~ ~National screening programmes include screening
178 IV, 12. 10 | screening programmes include screening for breast cancer, cervical
179 IV, 12. 10 | cervical cancer and foetal screening programmes, including screening
180 IV, 12. 10 | screening programmes, including screening for chromosomal and structural
181 IV, 12. 10 | It expands breast cancer screening for the age groups of 60
182 IV, 12. 10 | nature and scope of foetal screening programmes. The screening
183 IV, 12. 10 | screening programmes. The screening programmes will be regularly
184 IV, 12. 10 | Cancer and Cervical Cancer Screening Programmes~Psychosocial
185 IV, 13. 6. 2| advisory, preventive, and screening services for school children
186 IV, 13. 6. 2| school nurse, or doctor, screening children on a regular basis
187 IV, 13. 6. 2| difficult to define and measure. Screening services and immunisation,
